As shown in Figures 2, –4, after 8 weeks of decoction administration, there were no significant changes in serum TC, TNF-α, and IL-6 levels and liver MDA, SOD, and TC levels in CG-NASH (1.82 ± 0.21 nmol/L, 31.35 ± 3.10 ng/L, 8.81 ± 3.00 ng/L, 1.71 ± 0.46 nmol/ml, 57.18 ± 4.20 nmol/ml, and 0.35 ± 0.06 nmol/L, n = 10) and CG-NASH + GXZY (1.88 ± 0.25 nmol/L, 29.26 ± 3.30 ng/L, 9.21 ± 3.00 ng/L, 1.78 ± 0.43 nmol/ml, 55.36 ± 4.50 nmol/mL, and 0.37 ± 0.08 nmol/L, n = 10) mice. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.